3rd Quarter - Report
AKIN GUMP STRAUSS HAUER & FELD for AMGEN USA, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Home health options for Part B drugs; IPI/MFN proposal; proposal re pass-through extension in the Medicare OPPS payment system; legislative response to COVID-19; monitor drug pricing oversight and legislation including Prescription Drug Pricing Act (S. 2543), the Lower Costs, More Cures Act (S. 3129).
| Lobbyist | Covered position, as disclosed |
|---|---|
| GORDON HUNTER BATES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.